Cyclopharm Limited

A$0.46As of Sun 8 Nov 2026, 12:00 UTC
ASX:CYCHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (8.47%)
Div yield —
ROE (53.92%)
Medical Devices
Beta (5Y) 0.61
PE TTM —
TSR TTM (28.35%)
Mkt cap A$57.21M
ROIC (62.55%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.582
27.84%
(41.43%)
Hold 9|6|6|10|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
0.01
0.01
0.01
5.68%
13.44%
1.89%
14.25%
Revenue$M
4.395
4.347
4.293
4.197
17.96%
10.27%
7.63%
1.10%
Peers (US$39.29M)
Cap (US$)
PE
43.77M
—
39.44M
—
Capital
TTM
5Y
10Y
Leveragex
1.421
(0.738)
(0.608)
EBIT/Intx
1.929
0.155
0.144
Own earn%
(59.90)
36.88
33.03
Sh yield%
26.42
53.40
52.13
Owners
Insiders/Inst%
6.79
61.32
Short interest%
0.88
SBC / revenue%
5.90
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
20–25
$1 testx
0.1
Incr. ROIC%
1